By asianet
Lotus Pharmaceutical (1795: TT), a multinational pharmaceutical company, today reported its financial results for the third quarter ended 30 September 2022. Third quarter financial highlights: – Third quarter 2022 is the best quarter ever in the Company’s history, majorly driven by the successful launch of Lenalidomide in the US – the biggest launch in Lotus … Continued
By asianet
INT-787 is a selective next generation FXR agonist invented by TES Pharma and licensed to Intercept Pharmaceuticals INT-787 has shown strong anti-fibrotic and anti-inflammatory effects in animal models TES Pharma is dedicated to the identification of novel therapeutic targets and the discovery and development of new molecules to efficiently address the needs of patients with … Continued
By asianet
— The Novavax BA.1 vaccine candidate met its primary strain-change endpoint allowing for development of variant vaccines, if necessary — Novavax’ prototype vaccine induced broad immune response against original Wuhan, BA.1, and BA.5 strains — The trial showed no benefit for a bivalent vaccine utilizing Novavax’ recombinant protein/adjuvant technology Novavax, Inc. (Nasdaq: NVAX), a biotechnology … Continued
By asianet
– The ambitious EU initiative has already secured 2 billion euros of co-investment capabilities and has supported 60 innovative Biotech, Medtech & digital health start-ups to get to market or expand into new territories. – EIT Health, co-operator of the Venture Centre of Excellence alongside the European Investment Fund (EIF), has named ProductLife Group the … Continued
By asianet
OMRON Corporation headquartered in Shimogyo-ku, Kyoto, became a member of The Climate Group’s “EP100” (*1) initiatives. OMRON is the first Japanese company in the manufacturing industry and the fourth Japanese company in general to join the EP100 initiative, which brings together over 120 energy smart businesses committed to measuring and reporting on energy efficiency improvements. … Continued
By asianet
— Seasoned Executive has Successful Track Record Working with Global Investors to Raise Billions of Dollars Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced it has appointed Richard “Ric” Peterson as chief financial officer. Photo – https://mma.prnewswire.com/media/1935041/Turn_Biotechnologies_Ric_Peterson.jpg Logo – https://mma.prnewswire.com/media/1935529/TURN_LOGO_HI_RES_Logo.jpg Mr. Peterson, who has served as … Continued
By asianet
–United States-based National Comprehensive Cancer Network enters strategic cooperation agreement with Chinese medical information website to publish and translate evidence-based expert consensus guidelines for cancer care; now available at nccnchina.org.cn ( https://c212.net/c/link/?t=0&l=en&o=3691705-1&h=1106361729&u=http%3A%2F%2Fwww.nccnchina.org.cn&a=nccnchina.org.cn ). The National Comprehensive Cancer Network(R) (NCCN ( https://c212.net/c/link/?t=0&l=en&o=3691705-1&h=769424173&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN )(R))-an alliance of leading cancer centers ( https://c212.net/c/link/?t=0&l=en&o=3691705-1&h=3644457603&u=https%3A%2F%2Fwww.nccn.org%2Fhome%2Fmember-institutions&a=leading+cancer+centers ) in the United States-is announcing … Continued
By asianet
Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group (“Menarini”), a privately-held, leading international pharmaceutical company, today announced that the European Commission (EC) has granted orphan medicinal product designation for selinexor for the treatment of myelofibrosis (MF). Selinexor was granted orphan drug designation in MF by the … Continued
By asianet
– Lo.Li. Pharma International to unveil an innovative new product at CPHI Frankfurt, which has already gained the interest of numerous distribution partners. Pervistop[R] promises to be an extremely effective tool in the management of an exceedingly unpredictable disease. Lo.Li. Pharma International announces the pre-launch of a new, highly anticipated product at CPHI 2022, fulfilling … Continued
By asianet
EpiVax, Inc. (“EpiVax”) is pleased to announce participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for betacoronaviruses, including SARS-CoV-2. EpiVax will be carrying out the vaccine epitope selection portion of the collaboration using their comprehensive in silico vaccine design toolkit “iVAX” ( https://c212.net/c/link/?t=0&l=en&o=3692683-1&h=2887996362&u=https%3A%2F%2Fepivax.com%2Fimmunogenicity-assessment%2Fivax-web-based-vaccine-design&a=their+comprehensive+in+silico+vaccine+design+toolkit+%22iVAX%22 ). … Continued